Compare BBY & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBY | FMS |
|---|---|---|
| Founded | 1966 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 14.2B |
| IPO Year | 1994 | N/A |
| Metric | BBY | FMS |
|---|---|---|
| Price | $62.38 | $23.58 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 20 | 2 |
| Target Price | ★ $78.58 | $30.00 |
| AVG Volume (30 Days) | ★ 3.8M | 391.5K |
| Earning Date | 05-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 6.16% | 2.41% |
| EPS Growth | ★ 17.76 | N/A |
| EPS | ★ 5.04 | N/A |
| Revenue | ★ $41,691,000,000.00 | N/A |
| Revenue This Year | $1.22 | $0.45 |
| Revenue Next Year | $1.39 | $3.76 |
| P/E Ratio | ★ $12.34 | $15.62 |
| Revenue Growth | ★ 0.39 | N/A |
| 52 Week Low | $59.16 | $20.96 |
| 52 Week High | $84.99 | $30.46 |
| Indicator | BBY | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 43.27 | 61.76 |
| Support Level | $61.69 | $23.38 |
| Resistance Level | $68.68 | $24.08 |
| Average True Range (ATR) | 2.19 | 0.34 |
| MACD | 0.12 | 0.19 |
| Stochastic Oscillator | 39.47 | 88.14 |
With over $41 billion in consolidated 2024 sales, Best Buy is the largest pure-play consumer electronics retailer in the US, boasting roughly 8% share of the North American market and around 33% share of offline sales in the region, per our calculations, CTA, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the covid pandemic, have seen the US e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.